Earnings History Data for 9 Meters Biopharma, Inc. (NMTR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc. is a rare, orphan and unmet needs focused GI company. It's advancing NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for Short Bowel Syndrome, a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom. 9 Meters Biopharma Inc., formerly known as Innovate Bioph, is based in Raleigh, United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-03-2023	PM	NMTR	9 Meters Biopharma	17.00	-0.92	-0.80	0.00	9 Meters Biopharma GAAP EPS of -$0.92 misses by $0.12 [3/28/2023 8:52 AM]	1.35	0.01 (1.12%)	0.0	0.0 (0.00%)	1.00 - 13.20	52,212	80,000	0
9 Meters Biopharma GAAP EPS of -$0.92 misses by $0.12 [3/28/2023 8:52 AM]
08-11-2022	PM	NMTR	9 Meters Biopharma	28.00	-0.72	-0.83	0.00	9 Meters Biopharma GAAP EPS of -$0.72 beats by $0.10 [11/8/2022 8:53 AM]	2.19	-0.05 (-2.23%)	2.20	-0.04 (-1.79%)	2.11 - 24.80	70,407	70,000	733
9 Meters Biopharma GAAP EPS of -$0.72 beats by $0.10 [11/8/2022 8:53 AM] 9 Meters Biopharma Provides Business Update and Reports Financial Results for Third Quarter 2022 [Nov-08-22 08:00AM]
15-08-2022	PM	NMTR	9 Meters Biopharma	68.00	-0.04	-0.04	0.00	9 Meters Biopharma GAAP EPS of -$0.04 in-line [8/15/2022 7:53 AM]	3.76	-0.21 (-5.29%)	0.26	-0.01 (-2.60%)	3.68 - 12.42	14,481	20,000	66,475
9 Meters Biopharma GAAP EPS of -$0.04 in-line [8/15/2022 7:53 AM]
16-05-2022	PM	NMTR	9 Meters Biopharma	98.00	-0.04	-0.04	0.00	9 Meters Biopharma GAAP EPS of -$0.04 [5/16/2022 7:57 AM]	0.4105	0.03 (9.03%)	0.39	0.01 (3.59%)	0.35 - 1.55	2,518,238	1,250,000	10,276
9 Meters Biopharma GAAP EPS of -$0.04 [5/16/2022 7:57 AM] 9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022 [May-16-22 07:00AM]
23-03-2022	PM	NMTR	9 Meters Biopharma	149.00	-0.04	-0.04	0.00	9 Meters Biopharma Non-GAAP EPS of -$0.04 [3/23/2022 9:14 AM]	0.5650	-0.03 (-4.51%)	0.6068	0.02 (2.55%)	0.51 - 1.55	1,158,925	1,423,570	13,456
9 Meters Biopharma Non-GAAP EPS of -$0.04 [3/23/2022 9:14 AM] 9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2021 [Mar-23-22 07:00AM]
22-03-2021	AH	NMTR	9 Meters Biopharma, Inc.	335.61	N/A	-0.04	0.00	9 Meters Biopharma reports Q4 results [3/22/2021 4:05 PM]	1.50	-0.25 (-14.49%)	1.57	-0.19 (-10.80%)	0.38 - 2.26	9,417,334	4,410,000	338,504
9 Meters Biopharma reports Q4 results [3/22/2021 4:05 PM] 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020 [Mar-22-21 04:00PM]